5h-pyrido[3,2-b]indole compounds as anticancer agents
作者： Andrew P. Degnan , Jeffrey A. Deskus , John E. Starrett , William D. Schmitz , Patrice Gill
DOI:
关键词:
摘要: The present invention is directed to tricyclic compounds of formula (I), pharmaceutically acceptable compositions comprising the and said for use in methods treatment various disorders particular cancer.
lens.org 参考文章(37)
Justin Wong, Maximiliano Vasquez, Antibodies that bind csf1r ,(2011)
Yuval Zipory, Amir Gross, Eran Miller, Tal Hammer, Oz Cabiri, Over-wire implant contraction methods ,(2013)
Alfonso R. Gennaro, Remington: The Science and Practice of Pharmacy ,(2003)
Paul Ponath, Jose F. Ponte, Michael Rosenzweig, Combination therapies employing gitr binding molecules ,(2008)
Peter G. M. Wuts, Theodora W. Greene, Protective groups in organic synthesis ,(1981)
Tanay Kesharwani, Firoz Jaipuri, Xiaoxia Zhang, Mario R. Mautino, Sanjeev Kumar, Jesse Waldo, Imidazole derivatives as ido inhibitors ,(2010)
George V. Delucca, Christopher P. Mussari, David R. Tortolani, John S. Tokarski, Michael A. Poss, Derek J. Norris, Yufen Zhao, Claude A. Quesnelle, Patrice Gill, Daniel O'malley, Dharmpal S. Dodd, Wen-Ching Han, Ashvinikumar V. Gavai, Carbazole compounds useful as bromodomain inhibitors ,(2014)
Frank D. King, Medicinal chemistry : principles and practice Royal Society of Chemistry. ,(1994)
Kris Reedquist, Kevin Baker, Brian Wong, Emma Masteller, Julie Hambleton, James Allen Zanghi, Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (csf1r) ,(2013)
Solomon Langermann, Linda Liu, Shannon Marshall, Sheng Yao, Antibodies and other molecules that bind b7-h1 and pd-1 ,(2012)